TrialPapillomavirus research (Amsterdam, Netherlands)2018

Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine in Latin American girls, boys, and young women.

Ángela María Ruiz-Sternberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.